PeptideStack
5.2kquestions
20kanswers
220users

Why does the same chromatogram give a different purity at 214 nm and at 280 nm?

Asked 11 Jun 2024Modified 21 months agoViewed 8.9k times
22

A report I have includes traces at two wavelengths from the same injection, using a diode-array detector. The 214 nm trace integrates to 98.6% and the 280 nm trace to 99.5%. Same injection, same column, same run, same peaks in the same places — just two channels off one detector.

I had assumed wavelength was a sensitivity setting, so a higher number of impurities at one wavelength would mean the other simply could not see them and the answer was "use the more sensitive one". But that is not quite the shape of what I am seeing: some peaks appear at both wavelengths with different relative sizes, and at least one peak is present at 280 and essentially absent at 214, which is the wrong way round from what I expected.

What determines the ratio, and is there a defensible answer to which wavelength's number I should quote? And should I be suspicious of a vendor who reports at 280 nm?

hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

466 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

162 questions
shareeditfollowflag
AH
askedanja_hellstrom13k1611 Jun 2024
7The peak present at 280 and absent at 214 is the interesting one. That is probably not peptide at all. – charge_state_3 9 months ago
add a comment

3 Answers

Accepted answer first, then by votes
66

Accepted answer

The two wavelengths are looking at two different chromophores, so they weight the same mixture differently. Neither is a sensitivity setting; they answer different questions, and 214 nm is the right one for a purity claim.

What each wavelength sees

214 nm (or 210, 215, 220 depending on the method) is the tail of the amide n-to-pi* absorption of the peptide bond itself. Every residue in the backbone contributes. The consequence is that response is roughly proportional to the number of peptide bonds, which is to say roughly proportional to peptide mass. That approximate proportionality to mass is exactly what a purity percentage needs, and it is why every pharmacopoeial peptide-purity method sits in the 210 to 220 nm region.

280 nm sees only the aromatic side chains, and effectively only three of them. Standard molar extinction coefficients in water, per residue:

ChromophoreMolar extinction at 280 nm (per M per cm)
Tryptophan5500
Tyrosine1490
Cystine (disulfide)125
Everything else, including the backboneapproximately 0

So at 280 nm the detector is counting tryptophans, with a small contribution from tyrosines. For our two usual molecules:

  • Semaglutide: one Trp (position 31) and one Tyr (19). 5500 + 1490 = 6990
  • Tirzepatide: one Trp (25) and two Tyr (1 and 10). 5500 + 2 x 1490 = 8480

A single tryptophan is carrying 79% of semaglutide's 280 nm absorbance and 65% of tirzepatide's.

Worked: why an impurity's apparent level changes with wavelength

Take semaglutide and a truncation impurity comprising residues 7 to 30 — 24 residues, so it has Tyr19 but has lost Trp31. Suppose it is genuinely present at 2.00 mol% of the mixture.

At 214 nm, response scales with peptide bonds: 23 for the impurity, 30 for the parent. Relative response factor 23 / 30 = 0.767.

  • Impurity area contribution: 2.00 x 0.767 = 1.533
  • Parent: 98.00 x 1.000 = 98.000
  • Reported impurity: 1.533 / (98.000 + 1.533) = 1.54%
  • Reported purity: 98.46%

At 280 nm, response scales with the aromatic sum: the impurity has only Tyr, so 1490 against the parent's 6990. Relative response factor 1490 / 6990 = 0.213.

  • Impurity area contribution: 2.00 x 0.213 = 0.426
  • Reported impurity: 0.426 / (98.000 + 0.426) = 0.43%
  • Reported purity: 99.57%

Same vial, same injection, 98.46% versus 99.57%. The impurity did not shrink; the detector stopped counting the part of the molecule that was missing. A truncation that removes the tryptophan is nearly invisible at 280 nm, and truncations at the C-terminus are among the most common synthesis by-products.

Your peak that appears at 280 and not at 214

Almost certainly not a peptide. A species with a strong aromatic or conjugated chromophore and little peptide backbone will show that pattern: residual protecting groups and their scavenger adducts, dibenzofulvene and its piperidine adduct from Fmoc deprotection, trityl-derived species, some plasticisers, and dye or leachable contamination from a stopper or a filter. Several of these absorb well at 280 to 300 nm.

It is worth chasing rather than dismissing, because a non-peptide organic impurity is real material in the vial that a 214 nm purity figure may under-weight, and its identity tells you something about the purification. The way to chase it is the MS trace at that retention time. A diode-array report that includes a full spectrum for each peak makes this a thirty-second check: read the peak's absorbance maximum. Peptide impurities have essentially no maximum above 230 except a shoulder at 275 to 280 if they contain Trp or Tyr; a species with a clean maximum at 265 or 300 is something else.

Which number to quote, and whether to be suspicious

Quote 214 nm. It is the compendial region, it approximates mass proportionality, and it is what any comparison you make against another report will assume.

On suspicion: 280 nm as the primary purity wavelength for a peptide is either a mistake or a choice, and it reliably flatters. It should be treated as a method red flag on the same level as a 20-minute gradient. But 280 nm as a second channel is genuinely useful and its presence is a sign of a better report, not a worse one:

  • Ratio-based peak purity. If the 280/214 area ratio of an impurity differs from the parent's, the impurity has a different aromatic content — a direct structural clue that costs nothing. Truncations losing Trp show a low ratio; species that gained a chromophore show a high one.
  • Trp oxidation detection. Oxidation of tryptophan to N-formylkynurenine destroys the 280 nm absorbance and creates absorbance near 320 nm. An impurity with a suppressed 280/214 ratio and a rise at 320 is an oxidised-Trp variant, and 320 nm is a channel worth asking for on any Trp-containing peptide.
  • Detector linearity. A heavily loaded main peak can saturate the detector at 214 nm while remaining linear at 280, since the 280 absorbance is far weaker. Comparing the two channels catches saturation, which otherwise inflates purity by flattening the top of the main peak.

So: a report giving 214 nm as the purity figure and 280 nm alongside for structural information is doing it right. A report giving only 280 nm has chosen the number.

edited 19 Oct 2024 by coring_risk — tightened the wording; no substantive change

shareimprove this answerflag
CR
answered · acceptedcoring_risk17k1826 Sept 2024
8One tryptophan carrying 79% of the 280 nm signal makes the vulnerability obvious. Lose one residue, lose the detection. – gradient_slope 8 months ago
7The 320 nm channel for N-formylkynurenine is a genuinely useful trick I had not seen suggested before. – nkem_obiora 6 months ago
Detector saturation at 214 on an overloaded main peak is real and I have been caught by it. The 280 channel is the check. – marta_okonkwo 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
21

Adding a practical constraint on the 214 nm choice that limits which mobile phases you can use, because it connects the wavelength question to the acid question.

At 214 nm you are close to where the mobile phase itself starts absorbing, and several common additives are opaque there:

AdditivePractical UV cutoffUsable at 214 nm?
Trifluoroacetic acid, 0.1%~210 nmYes, but it absorbs enough to cause gradient baseline drift
Formic acid, 0.1%~210 nmYes, with similar drift
Phosphoric acid / phosphate, pH 2.5~195 nmYes, and it is the cleanest baseline of the three
Acetic acid, 0.1%~230 nmNo
Trifluoroethanol, TEAPvariesCheck before assuming
Acetonitrile~190 nmYes
Methanol~205 nmMarginal, and it raises viscosity

The TFA baseline drift is worth explaining because the fix looks like an error. As the gradient runs, the acetonitrile fraction rises, and because TFA's absorbance differs between the aqueous and organic phases the baseline climbs steadily through the run. On a 60-minute gradient this can be tens of milli-absorbance units of rise, which distorts integration of late-eluting peaks and makes small impurities near the end of the run hard to call.

The standard correction is to put slightly less TFA in the organic phase than in the aqueous — 0.085% in B against 0.100% in A is the classic pairing, tuned empirically until the baseline is flat. If you see a method table with mismatched acid concentrations, that is not a typo; it is somebody who has balanced their baseline. It is a small marker of a method that has been developed rather than copied.

Phosphate buffer avoids the problem entirely, has the lowest cutoff and gives the flattest baseline, which is one of several reasons pharmacopoeial peptide methods favour it. Its cost is that it is non-volatile and therefore incompatible with the mass spectrometer, so a lab running phosphate cannot give you identity confirmation from the same injection.

shareimprove this answerflag
DH
answeredDr_Jonas_Halvorsen41k3815 Sept 2024
12

A caution on the extinction-coefficient arithmetic in the accepted answer, since people take those numbers and over-apply them.

The 5500 and 1490 figures are for free amino acids or fully denatured peptides in water. In a folded or partly structured peptide the aromatic side chains can be buried, hydrogen bonded or stacked, and their extinction coefficients shift by up to about 10% either way, with tryptophan's maximum moving a few nanometres. Under the conditions in an RP gradient — high acetonitrile, low pH, elevated temperature — most short peptides are largely unstructured, so the free-residue values are a good approximation. But they are an approximation, and any calculation built on them carries that.

Two consequences worth having:

  • Do not use 280 nm absorbance to determine concentration on a peptide with one Trp unless you have to. The uncertainty is 5 to 10% before you account for anything else, which is worse than a properly calibrated 214 nm quantitation against a reference standard. It is a reasonable rough method when no standard exists, and it is not a content assay.
  • Relative response factors computed from residue counts are estimates, not corrections. The 23-over-30 peptide-bond ratio in the accepted answer captures the dominant term but ignores that individual residues contribute differently at 214 nm — the aromatics, His and the carboxylate side chains all add appreciably beyond the bare amide. Published per-residue values at 214 nm exist and give better estimates than bond counting, and a true correction requires an isolated impurity standard measured directly.

The direction of the argument survives all of that: 214 nm is approximately mass-proportional and 280 nm is not remotely so, and the gap between purity figures at the two wavelengths is a structural fact about the impurities rather than noise. Just do not present a bond-count RRF as a measured correction.

shareimprove this answerflag
DF
answeredDr_Colm_Fitzhenry85k24821 Jun 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.